Cite
HARVARD Citation
McCaughan, G. et al. (2018). Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15). Alimentary pharmacology & therapeutics. 47 (3), pp. 401-411. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McCaughan, G. et al. (2018). Sofosbuvir and daclatasvir therapy in patients with hepatitis C‐related advanced decompensated liver disease (MELD ≥ 15). Alimentary pharmacology & therapeutics. 47 (3), pp. 401-411. [Online].